Author(s):
                        Sudhir K Sadul,  D. Gavaskar,  R. A. Kalaivani
                    
                    
                        Email(s):
                        dramadan@scs-net.org ,  mandil@scs-net.org 
                    
                      
                        DOI:
                        10.5958/0974-360X.2018.00442.0     
                    
  
                    
                        Address:
                        Sudhir K Sadul, Mr. D. Gavaskar, Mrs.R. A. Kalaivani*
Department of Chemistry, Vels university, Pallavaram, Chennai-600043, Tamil Nadu, India
*Corresponding Author
                    
                    
                        Published In:
                         
                        Volume - 11,     
                                Issue - 6,    
                                Year - 2018
                        
                    
					
					
					
				
                 
				
                					
                    
                    
                        ABSTRACT: 
                        A PXRD quantitative method is developed and validated for the estimation of Aprepitant Form-II in Aprepitant Drug substance (mixture of Aprepitant Form-I and Form-II). The PXRD conditions for the Slow scan method developed for the estimation of Aprepitant Form-II at 12.6 with a radiation source of Copper Ka1 ( ? = 1.54060A°). The Angular range was 11.0 to 13.0°2? with the Voltage and Current set to 40KV and 40mA and a step size of 0.005° along with sample rotation of 30 rpm. The scan type is Locked coupled, continuous with a high sensitive Lynxeye detector. The developed method was validated for Specificity, Linearity, Precision, accuracy and Robustness. The PXRD method is Linear with a concentration range of 5% to 90% w/w. with correlation coefficient of 0.999. The recoveries ranged between 89.6% - 103.4% for 10% and 60% levels. The Method was found to be specific, linear, sensitive, precise, accurate and robust for the estimation of Aprepitant Form-II in Aprepitant Drug substance.
                    
                    
                    
                 
				
				
                    
                    
                        Cite this article:
                        
                        Sudhir K Sadul, D. Gavaskar, R. A. Kalaivani. Development and Validation of Method for the Estimation of Aprepitant Form-II in Aprepitant Drug Substance (Mixture of Aprepitant Form-I and Form-II) by Powder X-Ray Diffractometer (PXRD). Research J. Pharm. and Tech 2018; 11(6): 2393-2397. doi: 10.5958/0974-360X.2018.00442.0
						
						 Cite(Electronic):
						 
						 Sudhir K Sadul, D. Gavaskar, R. A. Kalaivani. Development and Validation of Method for the Estimation of Aprepitant Form-II in Aprepitant Drug Substance (Mixture of Aprepitant Form-I and Form-II) by Powder X-Ray Diffractometer (PXRD). Research J. Pharm. and Tech 2018; 11(6): 2393-2397. doi: 10.5958/0974-360X.2018.00442.0   Available on: https://rjptonline.org/AbstractView.aspx?PID=2018-11-6-43